• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肝硬化非酒精性脂肪性肝病中的门静脉血栓形成:一项为期9年的前瞻性队列研究

Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study.

作者信息

Abdel-Razik Ahmed, Mousa Nasser, Shabana Walaa, Yassen Ahmed H, Abdelsalam Mostafa, Wahba Mohamed M, Helmy Eman Mohamed, Tawfik Ahmed M, Zalata Khaled, Hasan Ahmad S, Elhelaly Rania, Elzehery Rasha, Fathy Aya Ahmed, El-Wakeel Niveen, Eldars Waleed

机构信息

Tropical Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

出版信息

Front Med (Lausanne). 2021 Apr 29;8:650818. doi: 10.3389/fmed.2021.650818. eCollection 2021.

DOI:10.3389/fmed.2021.650818
PMID:33996858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8117420/
Abstract

Approximately 30-40% of portal vein thrombosis (PVT) remains of unknown origin. The association between non-alcoholic fatty liver disease (NAFLD) and PVT is a matter of debate. This study aimed to investigate the association between PVT and NAFLD. We included 94 out of 105 consecutive NAFLD patients in this prospective cohort study in addition to 94 from the healthy control group. We evaluated biochemical, clinical, immunological, and histopathological parameters; waist circumference (WC); leptin; adiponectin; and leptin/adiponectin ratio (LAR) for all participants at baseline and every 3 years thereafter. We described the characteristics of participants at baseline and showed individual WC, LAR, and PVT characteristics. Potential parameters to predict PVT development within 9 years were determined. PVT developed in eight (8.5%) patients, mainly in the portal trunk. Univariate analysis showed three PVT-associated factors: diabetes mellitus ( = 0.013), WC ( < 0.001), and LAR ( = 0.002). After adjusting multiple confounding variables, the multivariate model showed that the only significant variables were WC and LAR. By applying the receiver operating characteristic curve, WC had 98.8% specificity, 87.5% sensitivity, and 0.894 area under the curve (AUC) for prediction of PVT ( < 0.001) at cutoff values of > 105 cm. In comparison, LAR had 60.5% specificity, 87.5% sensitivity, and 0.805 AUC for PVT prediction ( < 0.001) at cutoff values of >7.5. This study suggests that increased central obesity and LAR were independently associated with PVT development in non-cirrhotic NAFLD patients, and they should be considered risk factors that may participate in PVT multifactorial pathogenesis.

摘要

约30%-40%的门静脉血栓形成(PVT)病因不明。非酒精性脂肪性肝病(NAFLD)与PVT之间的关联存在争议。本研究旨在调查PVT与NAFLD之间的关联。在这项前瞻性队列研究中,我们纳入了105例连续的NAFLD患者中的94例,另外还有94例来自健康对照组。我们评估了所有参与者在基线时以及此后每3年的生化、临床、免疫和组织病理学参数;腰围(WC);瘦素;脂联素;以及瘦素/脂联素比值(LAR)。我们描述了基线时参与者的特征,并展示了个体WC、LAR和PVT的特征。确定了预测9年内PVT发生的潜在参数。8例(8.5%)患者发生了PVT,主要发生在门静脉主干。单因素分析显示了3个与PVT相关的因素:糖尿病(P=0.013)、WC(P<0.001)和LAR(P=0.002)。在调整多个混杂变量后,多变量模型显示唯一显著的变量是WC和LAR。通过应用受试者工作特征曲线,WC在预测PVT时,当截断值>105 cm时,特异性为98.8%,敏感性为87.5%,曲线下面积(AUC)为0.894(P<0.001)。相比之下,LAR在预测PVT时,当截断值>7.5时,特异性为60.5%,敏感性为87.5%,AUC为0.805(P<0.001)。本研究表明,中心性肥胖增加和LAR与非肝硬化NAFLD患者PVT的发生独立相关,它们应被视为可能参与PVT多因素发病机制的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2f/8117420/10ce36aa6fd9/fmed-08-650818-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2f/8117420/015eeab7a0dd/fmed-08-650818-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2f/8117420/e0f08dcacda0/fmed-08-650818-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2f/8117420/10ce36aa6fd9/fmed-08-650818-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2f/8117420/015eeab7a0dd/fmed-08-650818-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2f/8117420/e0f08dcacda0/fmed-08-650818-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f2f/8117420/10ce36aa6fd9/fmed-08-650818-g0003.jpg

相似文献

1
Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study.非肝硬化非酒精性脂肪性肝病中的门静脉血栓形成:一项为期9年的前瞻性队列研究
Front Med (Lausanne). 2021 Apr 29;8:650818. doi: 10.3389/fmed.2021.650818. eCollection 2021.
2
De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.肝硬化患者的新发门静脉血栓形成:危险因素及与终末期肝病模型评分系统的相关性
Eur J Gastroenterol Hepatol. 2015 May;27(5):585-92. doi: 10.1097/MEG.0000000000000325.
3
Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis.门静脉直径增加可预测肝硬化患者门静脉血栓形成。
Ann Transl Med. 2021 Feb;9(4):289. doi: 10.21037/atm-20-4912.
4
Central obesity is associated with non-cirrhotic portal vein thrombosis.中心性肥胖与非肝硬化性门静脉血栓形成有关。
J Hepatol. 2016 Feb;64(2):427-432. doi: 10.1016/j.jhep.2015.08.024. Epub 2015 Aug 31.
5
Visceral fat is associated with cirrhotic portal vein thrombosis.内脏脂肪与肝硬化门静脉血栓形成有关。
Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):1017-1022. doi: 10.1080/17474124.2019.1651644. Epub 2019 Aug 8.
6
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.预测非酒精性脂肪性肝病的脂肪肝指数与腰围对比
World J Gastroenterol. 2016 Mar 14;22(10):3023-30. doi: 10.3748/wjg.v22.i10.3023.
7
The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B.弥散性血管内凝血评分是乙型肝炎肝硬化患者门静脉血栓形成的新预测因子。
Thromb Res. 2018 Jan;161:7-11. doi: 10.1016/j.thromres.2017.11.010. Epub 2017 Nov 15.
8
High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.高密度脂蛋白胆固醇预测伴门静脉血栓形成的肝硬化患者死亡率:一项回顾性研究。
Lipids Health Dis. 2019 Mar 30;18(1):79. doi: 10.1186/s12944-019-1005-8.
9
[Correlational study on portal vein thrombosis of liver cirrhosis].[肝硬化门静脉血栓形成的相关性研究]
Zhonghua Gan Zang Bing Za Zhi. 2020 Jul 20;28(7):573-579. doi: 10.3760/cma.j.cn501113-20190404-00107.
10
Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis.非肿瘤性门静脉血栓形成患者的全血旋转血栓弹性描记术(ROTEM®)图谱。
Thromb Res. 2013 Aug;132(2):e131-4. doi: 10.1016/j.thromres.2013.06.009. Epub 2013 Jun 28.

引用本文的文献

1
An updated systematic review and meta-analysis: correlation between circulating plasminogen activator inhibitor-1 levels and metabolic dysfunction-associated steatotic liver disease.一项更新的系统评价与荟萃分析:循环纤溶酶原激活物抑制剂-1水平与代谢功能障碍相关脂肪性肝病之间的相关性
BMC Gastroenterol. 2025 Aug 20;25(1):604. doi: 10.1186/s12876-025-04148-8.
2
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.非酒精性脂肪性肝病或代谢相关脂肪性肝病患者 2 型糖尿病的全球流行病学:系统评价和荟萃分析。
BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0.
3
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies.

本文引用的文献

1
Fibrosis-4 (FIB-4) score at the primary care level: an analysis of over 160 000 blood samples.基层医疗水平的纤维化-4(FIB-4)评分:对超过16万份血样的分析
Gut. 2021 Jan;70(1):219-221. doi: 10.1136/gutjnl-2020-320995. Epub 2020 Apr 3.
2
Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients.肝硬化与非肝硬化患者门静脉系统血栓形成。
Ann Hepatol. 2018 May-June;17(3):476-481. doi: 10.5604/01.3001.0011.7392. Epub 2018 Apr 9.
3
Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications.
非酒精性脂肪性肝病患者门静脉血栓形成的患病率:观察性研究的荟萃分析。
J Thromb Thrombolysis. 2024 Feb;57(2):330-336. doi: 10.1007/s11239-023-02912-9. Epub 2023 Dec 8.
4
Association of nonalcoholic fatty liver disease with acute cholangitis: a nationwide propensity-matched analysis from the United States.非酒精性脂肪性肝病与急性胆管炎的关联:一项来自美国的全国性倾向匹配分析。
Proc (Bayl Univ Med Cent). 2023 Jul 17;36(5):600-607. doi: 10.1080/08998280.2023.2231721. eCollection 2023.
5
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications.非酒精性脂肪性肝病相关的凝血与内皮功能障碍:现状与治疗意义
J Clin Transl Hepatol. 2022 Apr 28;10(2):339-355. doi: 10.14218/JCTH.2021.00268. Epub 2022 Jan 12.
低分子肝素治疗肝硬化门静脉血栓形成:疗效和出血并发症风险。
Thromb Res. 2018 Mar;163:71-76. doi: 10.1016/j.thromres.2018.01.032. Epub 2018 Feb 2.
4
Central obesity is associated with non-cirrhotic portal vein thrombosis.中心性肥胖与非肝硬化性门静脉血栓形成有关。
J Hepatol. 2016 Feb;64(2):427-432. doi: 10.1016/j.jhep.2015.08.024. Epub 2015 Aug 31.
5
Portal vein thrombosis.门静脉血栓形成
J Clin Exp Hepatol. 2015 Mar;5(1):22-40. doi: 10.1016/j.jceh.2014.12.008. Epub 2015 Jan 6.
6
Differential effects of leptin and adiponectin in endothelial angiogenesis.瘦素和脂联素在内皮细胞血管生成中的不同作用
J Diabetes Res. 2015;2015:648239. doi: 10.1155/2015/648239. Epub 2015 Jan 15.
7
Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis.钙网织蛋白突变在肠系膜静脉血栓形成病因诊断中的作用。
J Hepatol. 2015 Jan;62(1):72-4. doi: 10.1016/j.jhep.2014.08.032. Epub 2014 Aug 27.
8
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.1980 至 2013 年期间全球、地区和国家儿童和成人超重和肥胖患病率:2013 年全球疾病负担研究的系统分析。
Lancet. 2014 Aug 30;384(9945):766-81. doi: 10.1016/S0140-6736(14)60460-8. Epub 2014 May 29.
9
Procoagulant imbalance in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的促凝失衡。
J Hepatol. 2014 Jul;61(1):148-54. doi: 10.1016/j.jhep.2014.03.013. Epub 2014 Mar 18.
10
Mechanisms linking leptin to arterial and venous thrombosis: potential pharmacological targets.瘦素与动静脉血栓形成的关联机制:潜在的药理学靶点。
Curr Pharm Des. 2014;20(4):635-40. doi: 10.2174/13816128113199990021.